Acute kidney injury: Fenoldopam infusion does not reduce the need for RRT in patients with AKI after cardiac surgery (Nature Clinical Practice Nephrology)

The dopamine D1 receptor agonist fenoldopam mesylate does not prevent deterioration of renal function in patients with early acute kidney injury (AKI) after cardiac surgery, according to new findings from a randomized controlled trial (RCT) by Tiziana Bove and colleagues. These data are particularly disappointing